H-Trp-Phe-OH is an antihypertensive dipeptide with angiotensin-converting enzyme (ACE) inhibitory activity; it dose-dependently increases nitric oxide (NO) levels and reduces endothelin-1 (ET-1) content; it has been shown to increase ovarian weight in female mice when administered subcutaneously at 2 mg/kg (six injections over three days).